I am a geneticist with expertise in clinical molecular genetics and clinical cytogenetics. My primary specialty is the use of molecular cytogenetics and molecular pathology to diagnose cancer.
Molecular cytogenetics is a continually expanding field due to the rapid progress in cancer genetics research. I closely monitor the new diagnostic and prognostic markers emerging from translational research in order to promptly develop the needed assays for clinical testing of patients.
My investigative research in cancer genetics involves the detection and cloning of new recurrent genomic rearrangements in human cancers. The goal of my work is to identify novel pathogenic molecules that can be used for genetic diagnosis of cancer and lead to improvement in the care of cancer patients.
- Clinical Expertise: Clinical Molecular Genetics and Cancer Cytogenetics
- Languages Spoken: English
- Education: MD, Shandong University School of Medicine (China); PhD, Shanghai Institute of Hematology, Shanghai Second Medical University (China)
- Fellowships: Weill Cornell Medical College; Memorial Sloan Kettering Cancer Center
- Board Certifications: Clinical Molecular Genetics
Wang L, Su XY, Cao Q, Chen SJ, Zhang LJ, Wang G, Zhao XT, Wan DF, Gu JR. Application of Comparative Genomic Hybridization for detection of genomic imbalance in tumors. Acta University of Yunnan. 1999, 21: 345-346 [in Chinese]
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more